ZNF224 and B-cell chronic lymphocytic leukemia: The data obtained from evaluating ZNF224 levels in our cohort of patients and the strong positive correlation of ZNF224 expression with some CLL predictive and prognostic markers, obtained by bioinformatic analysis, lead us to speculate that ZNF224 could represent a potential marker of disease progression and therapy responsiveness in CLL patients.